Epilepsy is one of the most common neurological conditions, affecting over 65 million individuals worldwide, and is characterized by recurrent, spontaneous, and uncontrollable seizures. Seizures commonly arise in the epileptic brain after a sudden burst in neurological activity. While many anti-epileptic drugs control seizures, one-third of patients with epilepsy fail to respond to them. Managing drug-resistant epilepsies poses a challenge to scientists and clinicians alike.
In this episode, narrated by Niki Spahich, Sejal Davla from The Scientist’s Creative Services team spoke with Evangelos Kiskinis, an assistant professor at Northwestern University Feinberg School of Medicine, about his work modeling drug-resistant epilepsies using induced pluripotent stem cells, which offers novel disease management solutions that could translate to the clinic.
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Axion BioSystems.